Fevipiprant inhibits eosinophil activation induced by multiple metabolites of prostaglandin D2

S. Carstensen (Hannover, Germany), M. Müller (Hannover, Germany), V. Erpenbeck (Basel, Switzerland), S. Kazani (Cambridge, United States of America), D. Sandham (Cambridge, United States of America)

Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Carstensen (Hannover, Germany), M. Müller (Hannover, Germany), V. Erpenbeck (Basel, Switzerland), S. Kazani (Cambridge, United States of America), D. Sandham (Cambridge, United States of America). Fevipiprant inhibits eosinophil activation induced by multiple metabolites of prostaglandin D2. 4391

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: